## 6.4 [Blinding, Masking]

This will be an open-label study using a Prospective Randomized Open Blinded End-point
(PROBE) approach. Patients and investigators will be aware of treatment assignments. How
‚Äê
ever, the outcome adjudication committee will be blinded to treatment allocation to minimize
bias.